a public good project by the
Synthesis
Company
of California

© 2026

Susan D. Rudin | doi.page

0 works0 citations0 h-index

Susan D. Rudin

Louis Stokes Cleveland VA Medical Center(US)Case Western Reserve University(US)

Publications by Year

Research Areas

Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Enterobacteriaceae and Cronobacter Research, Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing

Most-Cited Works

→ Treatment and Prevention of Rat Glioblastoma by Immunogenic C6 Cells Expressing Antisense Insulin-Like Growth Factor I RNA(1993)329 cited
→ Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study(2021)323 cited
→ Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?(2017)282 cited
→ A Potential Virulence Gene,hyl_Efm, Predominates inEnterococcus faeciumof Clinical Origin(2003)262 cited
→ Genomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Multiple Pathways of Resistance(2014)213 cited
→ Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan

(2010)

210 cited

→ Genetic Linkage and Cotransfer of a Novel, vanB -Containing Transposon (Tn 5382 ) and a Low-Affinity Penicillin-Binding Protein 5 Gene in a Clinical Vancomycin-Resistant Enterococcus faecium Isolate(1998)205 cited

→ Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality(2016)189 cited

→ Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network(2014)165 cited

→ Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234(2018)146 cited